Alloy vs Obu Health
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Alloy
Best for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directoryStarting at $80/mo
Obu Health
Best for Cost-conscious patients seeking a multi-product compounded-peptide platform (GLP-1 plus NAD+/sermorelin add-ons) with named 503A pharmacy transparency and a published LegitScript ID, who are comfortable contacting support for per-dose pricing and state eligibility.Starting at $149/mo
Side-by-Side Comparison
| Feature | Alloy | Obu Health |
|---|---|---|
| Overall Score | 7.4/10 | ✓7.5/10 |
| Starting Price | ✓$80/mo | $149/mo |
| Editorial Rating | 3.7 ★ /5 | ✓3.8 ★ /5 |
| Features | 8 features | ✓10 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Alloy
Pros
- ✓Broadest GLP-1 formulary in our catalog: brand Wegovy + brand Zepbound + oral Wegovy + compounded semaglutide + compounded tirzepatide + compounded liraglutide
- ✓All consulting doctors are certified by The Menopause Society — only ~1,000 such certified practitioners exist among ~20,000 OB-GYNs in the US
- ✓Brand-name Wegovy starting at $199/mo and compounded liraglutide starting at $80/mo cover both ends of the price/access spectrum
- ✓STARTGLP1 promo code knocks $50 off the first month per the public site
Cons
- ✗Not available in Louisiana or Mississippi (verified) — readers in those two states should be routed elsewhere
- ✗Initial consultation is $49 and is separate from medication cost — readers should know there's a non-refundable upfront fee
- ✗Menopause-specialty framing — best fit for women in menopause/perimenopause, not the right product for men or younger women whose primary need is weight loss
Obu Health
Pros
- ✓LegitScript-certified with publicly displayed ID (44206977)
- ✓Two named 503A compounding-pharmacy partners (Manifest Pharmacy SC + RX Compounding Store FL) — transparency above category baseline
- ✓Lower advertised semaglutide starting price ($190) than most multi-product peer platforms
- ✓Multi-product offering (GLP-1s + NAD+ + sermorelin + generic ED + birth control) for single-platform users
- ✓24-hour US board-certified physician response window
Cons
- ✗Per-dose pricing tiers not transparently published on product pages — only 'starting from' prices visible
- ✗No explicit state-coverage list disclosed; FAQ confirms restrictions exist 'based on state' without enumeration
- ✗Medical director not named publicly
- ✗No published consultation fee disclosure — unclear whether physician visit is included in medication price
- ✗All sales final per FAQ ('Federal and State law do not allow medication returns')
- ✗Subscription auto-renewal/cancellation mechanics minimally documented
Our Verdict
Obu Health edges out Alloy with a higher overall score of 7.5/10 and is particularly strong for Cost-conscious patients seeking a multi-product compounded-peptide platform (GLP-1 plus NAD+/sermorelin add-ons) with named 503A pharmacy transparency and a published LegitScript ID, who are comfortable contacting support for per-dose pricing and state eligibility.. Alloy remains a solid alternative, especially if you're looking for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directory.
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.